当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Kara Daniel
Diabetic foot ulcers (DFU) are the most costly and devastating complication of diabetes, affecting 15% of people with diabetes at some point in their lives. Based on strategies from the National Institute for Health and Clinical Excellence, early and effective management of DFU can reduce the severity of complications, such as avoidable amputation and possible death, and improve overall quality of life. Quality can be improved. Management of DFU should be optimized using a multidisciplinary team as it requires a holistic approach to wound management. Based on research, glycemic control, wound debridement, advanced dressings, and offloading modalities should always be part of DFU management. Moreover, in some cases, surgery to heal chronic ulcers and prevent recurrence should be considered an integral part of treatment. Additionally, hyperbaric oxygen therapy, electrical stimulation, negative pressure wound therapy, bioengineered skin, and growth factors can be used as adjunctive therapies for rapid healing of DFU. It is therefore suggested that appropriately educated patients should be encouraged to receive regular foot care to prevent DFU and its complications.